# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Windtree Therapeutics shares are trading higher Wednesday after the company completed enrollment of its SEISMiC Extension Phase...
Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT), a biotechnology company focused on ...
- SEC Filing
Windtree Therapeutics (NASDAQ:WINT) reported quarterly losses of $(20.91) per share which missed the analyst consensus estimate...
Windtree Therapeutics's (NYSE:WINT) short percent of float has fallen 17.46% since its last report. The company recently r...